|
|
Article: Anika Therapeutics Appoints Frank J. Luppino as Chief Operating Officer.
- Article from:
- Biotech Week
- Article date:
- June 10, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Anika Therapeutics, Inc. (NASDAQ:ANIK) announced the appointment of Frank J. Luppino as chief operating officer. Luppino was most recently vice president of operations at Bionostics, a privately held developer, manufacturer and distributor of turnkey products for critical healthcare OEMs. As an integral member of the management team implementing Anika's strategic growth plan, Luppino will oversee the operations, quality systems, regulatory and clinical affairs areas. Luppino previously served for eight years at Anika, culminating in the position of vice president of operations (see also Anika Therapeutics, Inc.).
"We expect Frank to be instrumental in the next ...
Related newspaper, magazine, and journal articles:
|
|
Article: Anika Therapeutics Announces Date of First Quarter ...
PR Newswire;
April 23, 2007 ;
700+ words
... ... 23 /PRNewswire-FirstCall/ -- Anika Therapeutics, Inc. today said it plans to issue ... before the starting time and reference Anika Therapeutics. In addition, the conference call ... protected event management site. About Anika Therapeutics, Inc. Headquartered in Woburn ...
|
|